{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:14:56Z","timestamp":1790777696445,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["309778\/2014-0"],"award-info":[{"award-number":["309778\/2014-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"name":"BME-Biotechnology FIKP"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.schres.2018.09.002","type":"journal-article","created":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T10:44:10Z","timestamp":1536317050000},"page":"162-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Color vision impairments in schizophrenia and the role of antipsychotic medication type"],"prefix":"10.1016","volume":"204","author":[{"given":"Thiago Monteiro Paiva","family":"Fernandes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Silverstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela D.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szabolcs","family":"K\u00e9ri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas Galdino","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata Lyra","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natanael Antonio","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2018.09.002_bb0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-5\u00ae)","author":"Association, A. P., & American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.schres.2018.09.002_bb0045","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.neubiorev.2007.09.004","article-title":"The possible role of retinal dopaminergic system in visual performance","volume":"32","author":"Brandies","year":"2008","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.schres.2018.09.002_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2013.00535","article-title":"Schizophrenia spectrum participants have reduced visual contrast sensitivity to chromatic (red\/green) and luminance (light\/dark) stimuli: new insights into information processing, visual channel function, and antipsychotic effects","volume":"4","author":"Cadenhead","year":"2013","journal-title":"Front. Psychol."},{"key":"10.1016\/j.schres.2018.09.002_bb2025","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.exer.2018.06.006","article-title":"Expression of dopamine D2 and D3 receptors in the human retina revealed by positron emission tomography and targeted mass spectrometry","volume":"175","author":"Caravaggio","year":"2018","journal-title":"Exp. Eye Res."},{"issue":"10","key":"10.1016\/j.schres.2018.09.002_bb2040","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1176\/appi.ajp.160.10.1795","article-title":"Effects of typical, atypical, and no antipsychotic drugs on visual contrast detection in schizophrenia","volume":"160","author":"Chen","year":"2003","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2018.09.002_bb0095","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1086\/518127","article-title":"Red-green color vision impairment in Duchenne muscular dystrophy","volume":"80","author":"Costa","year":"2007","journal-title":"Am. J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.schres.2018.09.002_bb2050","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1167\/iovs.14-16094","article-title":"Performance on the Farnsworth-Munsell 100-Hue Test Is Significantly Related to Nonverbal IQFM100 Test Significantly Related to NVIQ","volume":"56","author":"Cranwell","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.schres.2018.09.002_bb0110","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4103\/0019-5545.111475","article-title":"Current perspectives on chlorpromazine equivalents: comparing apples and oranges!","volume":"55","author":"Danivas","year":"2013","journal-title":"Indian J. Psychiatry"},{"issue":"24","key":"10.1016\/j.schres.2018.09.002_bb2020","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1016\/S0042-6989(97)00129-6","article-title":"Neurobiology of retinal dopamine in relation to degenerative states of the tissue","volume":"37","author":"Djamgoz","year":"1997","journal-title":"Vision Res."},{"issue":"5","key":"10.1016\/j.schres.2018.09.002_bb0140","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1475-1313.2010.00776.x","article-title":"Color vision impairment in type 2 diabetes assessed by the D-15d test and the Cambridge Colour Test","volume":"30","author":"Feitosa-Santana","year":"2010","journal-title":"Ophthalmic Physiol. Opt."},{"key":"10.1016\/j.schres.2018.09.002_bb0150","doi-asserted-by":"crossref","first-page":"85","DOI":"10.12688\/f1000research.10714.1","article-title":"Comparison of color discrimination in chronic heavy smokers and healthy subjects","volume":"6","author":"Fernandes","year":"2017","journal-title":"F1000Res"},{"issue":"1","key":"10.1016\/j.schres.2018.09.002_bb0155","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-16752-0","article-title":"Colour discrimination thresholds in type 1 bipolar disorder: a pilot study","volume":"7","author":"Fernandes","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.schres.2018.09.002_bb0145","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1037\/pne0000121","article-title":"Visual function alterations in epilepsy secondary to migraine with aura: A case report","volume":"11","author":"Fernandes","year":"2018","journal-title":"Psychol. Neurosci."},{"key":"10.1016\/j.schres.2018.09.002_bb2060","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2018.00288","article-title":"Tobacco Use Decreases Visual Sensitivity in Schizophrenia","volume":"9","author":"Fernandes","year":"2018","journal-title":"Front. Psychol."},{"key":"10.1016\/j.schres.2018.09.002_bb2090","series-title":"Discovering Statistics Using IBM SPSS Statistics","author":"Field","year":"2013"},{"issue":"12","key":"10.1016\/j.schres.2018.09.002_bb2045","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/01.opx.0000192351.63069.4a","article-title":"The reliability of the Lanthony Desaturated D-15 test","volume":"82","author":"Good","year":"2005","journal-title":"Optom. Vis. Sci."},{"issue":"9","key":"10.1016\/j.schres.2018.09.002_bb2070","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","article-title":"The Fagerstr\u00f6m Test for Nicotine Dependence: a revision of the Fagerstr\u00f6m Tolerance Questionnaire","volume":"86","author":"Heatherton","year":"1991","journal-title":"Br. J. Addict."},{"key":"10.1016\/j.schres.2018.09.002_bb0195","series-title":"The Series of Plates Designed as a Test for Colour-blindness","author":"Ishihara","year":"1972"},{"key":"10.1016\/j.schres.2018.09.002_bb2095","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.pnpbp.2013.07.024","article-title":"Perceptual and cognitive effects of antipsychotics in first-episode schizophrenia: the potential impact of GABA concentration in the visual cortex","volume":"47","author":"Kelemen","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2018.09.002_bb0205","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1037\/a0019610","article-title":"When doors of perception open: visual contrast sensitivity in never-medicated, first-episode schizophrenia","volume":"119","author":"Kiss","year":"2010","journal-title":"J. Abnorm. Psychol."},{"key":"10.1016\/j.schres.2018.09.002_bb0215","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/schbul\/sbp130","article-title":"The schizophrenia patient outcomes research team (PORT): updated treatment recommendations 2009","volume":"36","author":"Kreyenbuhl","year":"2010","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.schres.2018.09.002_bb2065","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1167\/iovs.17-22905","article-title":"Severe Loss of Tritan Color Discrimination in RPE65 Associated Leber Congenital Amaurosis","volume":"59","author":"Kumaran","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.schres.2018.09.002_bb2035","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev-med-050911-161504","article-title":"Update on Typical and Atypical Antipsychotic Drugs","volume":"64","author":"Meltzer","year":"2013","journal-title":"Annu. Rev. Med."},{"issue":"11","key":"10.1016\/j.schres.2018.09.002_bb2085","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/gps.1610","article-title":"The Addenbrooke\u2019s Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening","volume":"21","author":"Mioshi","year":"2006","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.schres.2018.09.002_bb0270","series-title":"Cambridge Colour Test Handbook","author":"Mollon","year":"2000"},{"issue":"5","key":"10.1016\/j.schres.2018.09.002_bb2030","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/oby.20101","article-title":"Electroretinographic detection of human brain dopamine response to oral food stimulation","volume":"21","author":"Nasser","year":"2013","journal-title":"Obesity (Silver Spring)"},{"issue":"3","key":"10.1016\/j.schres.2018.09.002_bb2080","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol. Rep."},{"issue":"2","key":"10.1016\/j.schres.2018.09.002_bb0300","doi-asserted-by":"crossref","first-page":"A290","DOI":"10.1364\/JOSAA.29.00A290","article-title":"Color discrimination across four life decades assessed by the Cambridge Colour Test","volume":"29","author":"Paramei","year":"2012","journal-title":"J. Opt. Soc. Am. A Opt. Image Sci. Vis."},{"key":"10.1016\/j.schres.2018.09.002_bb0305","series-title":"Encyclopedia of Color Science and Technology","first-page":"343","article-title":"Color perception and environmentally based impairments","author":"Paramei","year":"2016"},{"key":"10.1016\/j.schres.2018.09.002_bb0310","series-title":"Encyclopedia of Color Science and Technology","first-page":"407","article-title":"Color vision testing","author":"Paramei","year":"2016"},{"issue":"4","key":"10.1016\/j.schres.2018.09.002_bb0315","doi-asserted-by":"crossref","first-page":"A375","DOI":"10.1364\/JOSAA.31.00A375","article-title":"Variation of color discrimination across the life span","volume":"31","author":"Paramei","year":"2014","journal-title":"J. Opt. Soc. Am. A"},{"issue":"10","key":"10.1016\/j.schres.2018.09.002_bb0325","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/0042-6989(94)90203-8","article-title":"Luminance noise and the rapid determination of discrimination ellipses in colour deficiency","volume":"34","author":"Regan","year":"1994","journal-title":"Vis. Res."},{"key":"10.1016\/j.schres.2018.09.002_bb2015","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0079-6123(08)00908-4","article-title":"Role of serotonin and dopamine receptor binding in antipsychotic efficacy","volume":"172","author":"Richtand","year":"2008","journal-title":"Prog. Brain Res."},{"issue":"2","key":"10.1016\/j.schres.2018.09.002_bb2075","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1590\/S0102-79722003000200007","article-title":"Visual processing of form in the aged: threshold contrast curves to angular and spatial frequency","volume":"16","author":"Santos","year":"2003","journal-title":"Psicol. Reflex. Crit."},{"issue":"1","key":"10.1016\/j.schres.2018.09.002_bb0355","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1134\/S0362119714010150","article-title":"Frequency-contrast sensitivity of visual stimulus perception in patients with schizophrenia treated with atypical and typical antipsychotics","volume":"40","author":"Shoshina","year":"2014","journal-title":"Hum. Physiol."},{"key":"10.1016\/j.schres.2018.09.002_bb0360","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0920-9964(01)00180-3","article-title":"Color discrimination in schizophrenia","volume":"55","author":"Shuwairi","year":"2002","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2018.09.002_bb2005","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-3-319-30596-7_4","article-title":"Visual Perception Disturbances in Schizophrenia: A Unified Model","volume":"63","author":"Silverstein","year":"2016","journal-title":"Nebr. Symp. Motiv."},{"issue":"2","key":"10.1016\/j.schres.2018.09.002_bb2010","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.scog.2015.03.004","article-title":"Schizophrenia and the eye","volume":"2","author":"Silverstein","year":"2015","journal-title":"Schizophr. Res. Cogn."},{"issue":"1","key":"10.1016\/j.schres.2018.09.002_bb2055","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1037\/0021-843X.110.1.6","article-title":"Demonstrating specific cognitive deficits: a psychometric perspective","volume":"110","author":"Strauss","year":"2001","journal-title":"J. Abnorm. Psychol."},{"key":"10.1016\/j.schres.2018.09.002_bb0390","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1023\/B:DOOP.0000019487.88486.0a","article-title":"Dopamine and retinal function","volume":"108","author":"Witkovsky","year":"2004","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.schres.2018.09.002_bb0395","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4088\/JCP.v64n0607","article-title":"Chlorpromazine equivalent doses for the newer atypical antipsychotics","volume":"64","author":"Woods","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2018.09.002_bb0415","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2017.01127","article-title":"Color vision losses in autism spectrum disorders","volume":"8","author":"Zachi","year":"2017","journal-title":"Front. Psychol."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996418305516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996418305516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T15:38:23Z","timestamp":1565278703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996418305516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":42,"alternative-id":["S0920996418305516"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2018.09.002","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Color vision impairments in schizophrenia and the role of antipsychotic medication type","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2018.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}